Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnese Restuccia

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Oncotarget|December 18, 2015
Mps1 is SUMO-modified during the cell cycleAgnese Restuccia, Feikun Yang, Changyan Chen, et al.
Virology|July 30, 2013
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alphaTeresa Pollicino, Luigi Bellinghieri, Agnese Restuccia, et al.
Hepatology (Baltimore, Md.)|January 25, 2012
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levelsTeresa Pollicino, Giuliana Amaddeo, Agnese Restuccia, et al.
Gastroenterology|February 8, 2018
HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of InterferonPascal Mutz, Philippe Metz, Florian A Lempp, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Oncotarget|December 18, 2015
Mps1 is SUMO-modified during the cell cycleAgnese Restuccia, Feikun Yang, Changyan Chen, et al.
Virology|July 30, 2013
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alphaTeresa Pollicino, Luigi Bellinghieri, Agnese Restuccia, et al.
Hepatology (Baltimore, Md.)|January 25, 2012
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levelsTeresa Pollicino, Giuliana Amaddeo, Agnese Restuccia, et al.
Gastroenterology|February 8, 2018
HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of InterferonPascal Mutz, Philippe Metz, Florian A Lempp, et al.
Pageof 1